妊娠期乳腺癌诊治策略

doi:10.16139/j.1007-9610.2019.05.007

摘要/Abstract

关键词: 妊娠期乳腺癌, 粗针穿刺活检, 前哨淋巴结活检, BRCA1/2 检测, 手术

中图分类号:

R737.9

汤永喆, 王杰, 何奇. 妊娠期乳腺癌诊治策略[J]. 外科理论与实践, 2019, 24(05): 400-405.

[1] Polivka J Jr, Altun I, Golubnitschaja O.Pregnancy-associated breast cancer: the risky status quo and new concepts of predictive medicine[J]. EPMA J,2018,9(1):1-13.
[2] Ruiz R, Herrero C, Strasser-Weippl K, et al.Epidemiology and pathophysiology of pregnancy-associated breast cancer: A review[J]. Breast,2017,35:136-141.
[3] Royal College of Obstetricians and Gynaecologists. Pregnancy and Breast Cancer, Green-top Guideline[R].[2019-7-29]. https://www.rcog.org.uk/globalassets/documents/guidelines/gtg_12.pdf
[4] Amant F, Loibl S, Neven P, et al.Breast cancer in pregnancy[J]. Lancet,2012,379(9815):570-579.
[5] Genin AS, Lesieur B, Gligorov J, et al.Pregnancy-associa-ted breast cancers: do they differ from other breast cancers in young women[J]. Breast,2012,21(4):550-555.
[6] Johansson ALV, Weibull CE, Fredriksson I, et al.Diagnostic pathways and management in women with pregnancy-associated breast cancer (PABC): no evidence of treatment delays following a first healthcare contact[J]. Breast Cancer Res Treat,2019,174(2):489-503.
[7] Azim HA Jr, Santoro L, Russell-Edu W, et al.Prognosis of pregnancy-associated breast cancer: a meta-analysis of 30 studies[J]. Cancer Treat Rev,2012,38(7):834-842.
[8] 中国抗癌协会乳腺癌专业委员会. 中国抗癌协会乳腺癌诊治指南与规范(2019年版)[J]. 中国癌症杂志,2019,29(8):609-680.
[9] 中国临床肿瘤学会指南工作委员会. 中国临床肿瘤学会(CSCO)乳腺癌诊疗指南[M]. 北京:人民卫生出版社,2019:48-56
[10] National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology,. Breast Cancer [EB/OL]. Version 1.2019. [2019-7-29]. https://www.nccn.org/patients/default.aspx.
[11] Liedtke C, Jackisch C, Thill M, et al.AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer[EB/OL]. [2019-7-29]. https://www.ago-online.de
[12] Peccatori FA, Azim HA Jr, Orecchia R, et al. Cancer, pregnancy and fertility: ESMO Clinical Practice Guidelines for diagnosis treatment and follow-up[J]. Ann Oncol,2013,24(Suppl 6):vi160-170.
[13] Robbins J, Jeffries D, Roubidoux M, et al.Accuracy of diagnostic mammography and breast ultrasound during pregnancy and lactation[J]. Am J Roentgenol,2011,196(3):716-722.
[14] Tremblay E, Thérasse E, Thomassin-Naggara I, et al.Quality initiatives: guidelines for use of medical imaging during pregnancy and lactation[J]. Radiographics,2012, 32(3):897-911.
[15] Cordeiro CN, Gemignani ML.Breast cancer in pregnancy: avoiding fetal harm when maternal treatment is necessary[J]. Breast J,2017,23(2):200-205.
[16] Wang PI, Chong ST, Kielar AZ, et al.Imaging of pregnant and lactating patients: part 1, evidence-based review and recommendations[J]. Am J Roentgenol,2012,198(4):778-784.
[17] Gentilini O, Cremonesi M, Trifirò G, et al.Safety of sentinel node biopsy in pregnant patients with breast cancer[J]. Ann Oncol,2004,15(9):1348-1351.
[18] Toesca A, Gentilini O, Peccatori F, et al.Locoregional treatment of breast cancer during pregnancy[J]. Gynecological Surgery,2014,11(4):279-284
[19] Daly MB, Pilarski R, Berry M, et al.NCCN Guidelines insights: Genetic/Familial High-Risk Assessment: Breast and ovarian, Version 2.2017[J]. J Natl Compr Canc Netw,2017,15(1):9-20.
[20] Couch FJ, Hart SN, Sharma P, et al.Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer[J]. J Clin Oncol,2015,33(4):304-311.
[21] Nancie P, Mary BD, Tuya P.BRCA1- and BRCA2-Associated Hereditary Breast and Ovarian Cancer[EB/OL]. [2019-7-29].https://www.ncbi.nlm.nih.gov/books/NBK1247/.
[22] Byrski T, Dent R, Blecharz P, et al.Results of a phase Ⅱopen-label, non-randomized trial of cisplatin chemotherapy in patients with BRCA1-positive metastatic breast cancer[J]. Breast Cancer Res,2012,14(4):R110.
[23] Rosen MA.Management of anesthesia for the pregnant surgical patient[J]. Anesthesiology,1999,91(4):1159-1163.
[24] Shachar SS, Gallagher K, McGuire K, et al. Multidisciplinary management of breast cancer during pregnancy[J]. Oncologist,2017,22(3):324-334.
[25] Lohsiriwat V, Peccatori FA, Martella S, et al.Immediate breast reconstruction with expander in pregnant breast cancer patients[J]. Breast,2013,22(5):657-660.
[26] Martin DD.Review of radiation therapy in the pregnant cancer patient[J]. Clin Obstet Gynecol,2011,54(4):591-601.
[27] Loibl S, Schmidt A, Gentilini O, et al.Breast cancer dia-gnosed during pregnancy: adapting recent advances in breast cancer care for pregnant patients[J]. JAMA Oncol,2015,1(8):1145-1153.
[28] Lambertinia M, Di Maio M, Paganic O, et al.The BCY3/BCC 2017 survey on physicians' knowledge, attitudes and practice towards fertility and pregnancy-related issues in young breast cancer patients[J]. Breast,2018,42:41-49.
[29] Cardonick E, Bhat A, Gilmandyar D, et al.Maternal and fetal outcomes of taxane chemotherapy in breast and ovarian cancer during pregnancy: Case series and review of the literature[J]. Ann Oncol,2012,23(12):3016-3023.
[30] Tutt A, Tovey H, Cheang MCU, et al.Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial[J]. Nat Med,2018, 24(5):628-637.
[31] Alsop K, Fereday S, Meldrum C, et al.BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group[J]. J Clin Oncol,2012,30(21):2654-2663.
[32] von Minckwitz G, Schneeweiss A, Loibl S, et al. Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (GeparSixto; GBG 66): a randomised phase 2 trial[J]. Lancet Oncol,2014,15(7):747-756.
[33] Zagouri F, Psaltopoulou T, Dimitrakakis C, et al. Challenges in managing breast cancer during pregnancy[J]. J Thorac Dis,2013,Suppl 1:S62-S67
[34] Goetz O, Burgy C, Langer C, et al.Breastfeeding after breast cancer: survey to hospital health professionals in Alsace[J]. Gynecol Obstet Fertil,2014,42(4):234-239.
[35] Litton JK, Theriault RL.Breast cancer and pregnancy: current concepts in diagnosis and treatment[J]. Oncologist,2010,15(12):1238-1247.
[36] Stopenski S, Aslam A, Zhang X, et al.After chemotherapy treatment for maternal cancer during pregnancy, is breastfeeding possible?[J]. Breastfeed Med,2017,12:91-97.

妊娠期乳腺癌诊治策略

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	张小丽　李赞　宋达疆　王业成　海涛. 带蒂胸外侧动脉穿支皮瓣在保乳术后即刻乳房重建中的临床应用[J]. 组织工程与重建外科杂志, 2022, 18(5): 382-.
[2]	黎行宙　张紫薇　言颖杰　陈骁俊　张艳. 一款新型人机协作开颅手术机器人的动物实验研究：精确性和安全性分析[J]. 组织工程与重建外科杂志, 2022, 18(4): 289-.
[3]	尹彦江, 罗治文, 陈晓, 张业繁, 黄振, 赵宏, 赵建军, 李智宇, 周健国, 蔡建强, 毕新宇. 肝内胆管癌病人肝脏手术切缘与预后的关系[J]. 外科理论与实践, 2022, 27(3): 221-228.
[4]	宣呈杰, 卞冬生, 蒋咏梅, 陈宇菲, 金佳斌, 施咏梅. 营养治疗对减重术后身体成分及静息能量消耗的影响[J]. 外科理论与实践, 2022, 27(3): 244-248.
[5]	朱海男　顾斌　谢峰　余庆雄　盛玲玲　李青峰. 带血供复合组织同种异体移植的手术前评估[J]. 组织工程与重建外科杂志, 2022, 18(3): 265-.
[6]	周晓萍　陈萍. 自体肋软骨移植治疗Binder综合征的围手术期护理[J]. 组织工程与重建外科杂志, 2022, 18(2): 157-.
[7]	赵京京　吴镝. 上唇缺损修复手术方法研究进展[J]. 组织工程与重建外科杂志, 2022, 18(2): 183-.
[8]	陈小松, 沈坤炜, 李宏为. 早期可手术乳腺癌的诊治现状与展望[J]. 外科理论与实践, 2022, 27(05): 385-386.
[9]	谢妍妍, 吕青, 杜正贵. 乳腺腔镜和机器人手术的现状及未来之路——华西医院经验分享[J]. 外科理论与实践, 2022, 27(05): 396-402.
[10]	曹璐, 郑思悦, 陈佳艺. 早期乳腺癌区域淋巴结局部处理[J]. 外科理论与实践, 2022, 27(05): 406-410.
[11]	程威, 黄雨桦, 王剑, 李幼生. 影响癌性肠梗阻病人预后的多因素分析[J]. 外科理论与实践, 2022, 27(04): 340-345.
[12]	郭良奇, 严志龙, 张谋成. 腹腔镜经胃腔手术治疗胃黏膜下肿瘤和早期胃癌[J]. 外科理论与实践, 2022, 27(04): 380-383.
[13]	徐敏, 张京岚. 非心脏手术后新发心房颤动患者的相关临床分析[J]. 内科理论与实践, 2022, 17(04): 334-336.
[14]	孙惠川. 肝细胞癌转化治疗的现状与展望[J]. 外科理论与实践, 2022, 27(02): 134-138.
[15]	王贵福, 刘仁杰, 柏斗胜, 蒋国庆, 张弛, 王谦, 王翱卿, 金圣杰. 胆石性肠梗阻的诊断与治疗[J]. 外科理论与实践, 2022, 27(02): 169-172.